Your browser doesn't support javascript.
loading
Recombinant Antibodies against Mycolactone.
Naranjo, Leslie; Ferrara, Fortunato; Blanchard, Nicolas; Demangel, Caroline; D'Angelo, Sara; Erasmus, M Frank; Teixera, Andre A; Bradbury, Andrew R M.
Afiliação
  • Naranjo L; Specifica Inc., Santa Fe, NM 87505, USA. lnaranjo@specifica.bio.
  • Ferrara F; Specifica Inc., Santa Fe, NM 87505, USA. fferrara@specifica.bio.
  • Blanchard N; Université de Haute-Alsace, Université de Strasbourg, CNRS, LIMA, UMR 7042, 68000 Mulhouse, France. n.blanchard@unistra.fr.
  • Demangel C; Immunobiology of Infection Unit, Institut Pasteur, INSERM U1221, 75015 Paris, France. caroline.demangel@pasteur.fr.
  • D'Angelo S; Specifica Inc., Santa Fe, NM 87505, USA. sdangelo@specifica.bio.
  • Erasmus MF; Specifica Inc., Santa Fe, NM 87505, USA. ferasmus@specifica.bio.
  • Teixera AA; Specifica Inc., Santa Fe, NM 87505, USA. ateixeira@specifica.bio.
  • Bradbury ARM; New Mexico Consortium, Los Alamos, NM 87544, USA. ateixeira@specifica.bio.
Toxins (Basel) ; 11(6)2019 06 17.
Article em En | MEDLINE | ID: mdl-31212961
ABSTRACT
In the past, it has proved challenging to generate antibodies against mycolactone, the primary lipidic toxin A of Mycobacterium ulcerans causing Buruli ulcer, due to its immunosuppressive properties. Here we show that in vitro display, comprising both phage and yeast display, can be used to select antibodies recognizing mycolactone from a large human naïve phage antibody library. Ten different antibodies were isolated, and hundreds more identified by next generation sequencing. These results indicate the value of in vitro display methods to generate antibodies against difficult antigenic targets such as toxins, which cannot be used for immunization unless inactivated by structural modification. The possibility to easily generate anti-mycolactone antibodies is an exciting prospect for the development of rapid and simple diagnostic/detection methods.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Macrolídeos / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: Toxins (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Macrolídeos / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: Toxins (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos